NewLimit
Jenny Ng is a Research Associate II at NewLimit and the Buck Institute for Research on Aging, with experience in engineering CAR-SynNotch Treg cells for drug delivery and modeling Alzheimer's Disease in three-dimensional neuronal cultures. Previously, Jenny held the position of Research Fellow at SENS Research Foundation, focusing on identifying immune perturbations in Alzheimer’s mouse models. Jenny also served as a researcher at Cornell University College of Veterinary Medicine. Jenny obtained a Bachelor of Arts in Biological Sciences from Cornell University and is currently pursuing a post-baccalaureate in Computer Science at Tufts University.
NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.